Experts divided on Trumps new healthcare policy proposal

Here is a rewritten version of the news article in a neutral newsroom style:

A new health care plan has been unveiled by President Trump, which aims to address issues with prescription drug prices. The plan’s details have sparked mixed reactions among policy experts.

According to reports, the plan seeks to reduce costs associated with middlemen involved in the pharmaceutical supply chain. Some sources suggest that this could involve changes to how medications are distributed and priced.

The White House has released a statement outlining key components of the plan, but some experts have expressed concerns about its potential impact on healthcare access and affordability.

Details of the plan include proposals for reducing prices and increasing transparency in the pharmaceutical industry. However, specifics remain scarce, with many experts citing a lack of detail as a major concern.

The plan’s unveiling has sparked debate among policymakers and health care professionals, with some expressing skepticism about its feasibility and potential consequences.

Source: Google News World